Laura Cascarano

ORCID: 0009-0004-1715-8901
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Respiratory Support and Mechanisms
  • Cardiac Arrest and Resuscitation
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Resistance in Bacteria
  • Thermal Regulation in Medicine
  • Intensive Care Unit Cognitive Disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • Hemodynamic Monitoring and Therapy
  • Neutropenia and Cancer Infections
  • Pneumonia and Respiratory Infections
  • Vitamin D Research Studies
  • Pharmacological Effects and Toxicity Studies
  • Cardiovascular Health and Disease Prevention
  • Mechanical Circulatory Support Devices
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Acute Kidney Injury Research
  • Family and Patient Care in Intensive Care Units
  • Nosocomial Infections in ICU
  • Anesthesia and Sedative Agents
  • Electrolyte and hormonal disorders
  • Long-Term Effects of COVID-19

Agostino Gemelli University Polyclinic
2020-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2020-2024

Università Cattolica del Sacro Cuore
2020-2023

<h3>Importance</h3> High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic respiratory failure and widely applied in patients with COVID-19. <h3>Objective</h3> To assess whether helmet noninvasive ventilation can increase the days free of support COVID-19 compared high-flow alone. <h3>Design, Setting, Participants</h3> Multicenter randomized clinical trial 4 intensive care units (ICUs) Italy between October December 2020, end follow-up February 11, 2021, including 109...

10.1001/jama.2021.4682 article EN cc-by JAMA 2021-03-25

Abstract Background In critically ill patients, the use of high tigecycline dosages (HD TGC) (200 mg/day) has been recently increasing but few pharmacokinetic/pharmacodynamic (PK/PD) data are available. We designed a prospective observational study to describe profile HD TGC in cohort patients with severe infections. Results This was single centre, prospective, that conducted 20-bed mixed ICU 1500-bed teaching hospital Rome, Italy. all admitted between 2015 and 2018, who received mg loading...

10.1186/s13613-020-00715-2 article EN cc-by Annals of Intensive Care 2020-07-13

BACKGROUND Arterial hypotension during major surgery is related to postoperative complications and mortality. Both fluids vasopressors increase blood pressure (BP) by inducing different physiological response. We devised a protocol which relies on dynamic arterial elastance (Ea dyn ) guide BP optimisation abdominal surgery, tested its effectiveness tissue perfusion. OBJECTIVE explore if an Ea -based could affect lactate levels, fluid administration, clinical complications. DESIGN randomised...

10.1097/eja.0000000000002162 article EN European Journal of Anaesthesiology 2025-03-12

Abstract Background Long-term outcomes of patients treated with helmet noninvasive ventilation (NIV) are unknown: safety concerns regarding the risk patient self-inflicted lung injury and delayed intubation exist when NIV is applied in hypoxemic patients. We assessed 6-month outcome who received or high-flow nasal oxygen for COVID-19 respiratory failure. Methods In this prespecified analysis a randomized trial versus (HENIVOT), clinical status, physical performance (6-min-walking-test 30-s...

10.1186/s40560-023-00669-0 article EN cc-by Journal of Intensive Care 2023-05-19

To explore the association between endotoxin activity (EA) and septic cardiomyopathy (SCM), relationship removal by Polymyxin-B hemoperfusion (PMX-HP) recovery from SCM (R-SCM), correlation R-SCM 28-day mortality in patients admitted to intensive care unit (ICU).Observational study that included two ICUs of a tertiary university hospital April 2011 December 2019, who received PMX-HP for sepsis/septic shock. The were assessed transthoracic echocardiography.Among 148 patients, was diagnosed 60...

10.1111/aor.14645 article EN Artificial Organs 2023-09-22

Abstract Background In critically ill patients, the use of high tigecycline dosages (HD TGC) (200 mg/day) has been recently increasing but few pharmacokinetic/pharmacodynamic (PK/PD) data are available. We investigated plasmatic and pulmonary concentrations HD TGC in treatment severe infections. Methods This was a single centre, prospective, observational study that conducted twenty-bed mixed ICU 1,500- bed teaching hospital Rome, Italy. all patients admitted to between 2015 2018, who...

10.21203/rs.3.rs-15408/v1 preprint EN cc-by Research Square (Research Square) 2020-02-28
Coming Soon ...